Linden Capital Partners Hires Michael Farah as Principal
Chicago, Illinois (May 13, 2014) – Linden Capital Partners (“Linden”), a middle market healthcare private equity firm, today announced that Michael Farah has joined the firm as a Principal. Mr. Farah will complement and augment Linden’s team of investment professionals, working closely with operating partners and the management teams of Linden’s portfolio companies. Mr. Farah joins Linden from Metalmark Capital where he focused on healthcare investing for the last six years and was a board member of Aegis Sciences, Bostwick Laboratories, and Healogics.
Mr. Farah started his career in the healthcare investment banking group at UBS and spent three years as a private equity associate with Summit Partners. He holds a Bachelor of Science in Business Administration, with Honors, from Carnegie Mellon University and an MBA from Harvard Business School.